Pharmacotherapeutic management of lower urinary tract symptoms in Multiple Sclerosis patients.

LUTS affect the quality of life substantially and are associated with a significantly increased mortality. The adequate management is an important challenge for both patients and caregivers with a multidisciplinary approach likely necessary.